By Dr Deepu
Combination therapy was significantly more effective
than monotherapy for slowing disease progression in patients with
pulmonary arterial hypertension.
Investigators found that “compared with treatment with a single drug,
combination therapy was associated with a significantly lower risk for clinical
disease worsening and disease-related hospital admissions, and it was
associated with a trend toward reduced all-cause mortality and pulmonary arterial hypertension (PAH)-related mortality.” The findings were published in
Lancet Respiratory Medicine.
Source: read Full article on LANCET